Phenotypic correlations of CALR mutation variant allele frequency in patients with myelofibrosis

Blood Cancer J. 2023 Jan 30;13(1):21. doi: 10.1038/s41408-023-00786-x.

Authors

Paola Guglielmelli^#¹, Chiara Maccari^#¹, Benedetta Sordi¹, Manjola Balliu¹, Alessandro Atanasio¹, Carmela Mannarelli¹, Giulio Capecchi¹, Ilaria Sestini¹, Giacomo Coltro¹, Giuseppe Gaetano Loscocco^{1

2}, Giada Rotunno¹, Eva Angori³, Filippo C Borri³, Ayalew Tefferi^#⁴, Alessandro M Vannucchi^#⁵

Affiliations

¹ CRIMM, Center Research and Innovation of Myeloproliferative Neoplasms, University of Florence, AOU Careggi, Florence, Italy.
² Doctorate School GenOMec, University of Siena, Siena, Italy.
³ University of Florence, Florence, Italy.
⁴ Division of Hematology, Mayo Clinic, Rochester, MN, USA.
⁵ CRIMM, Center Research and Innovation of Myeloproliferative Neoplasms, University of Florence, AOU Careggi, Florence, Italy. [email protected].

^# Contributed equally.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Calreticulin / genetics
Gene Frequency
Humans
Janus Kinase 2 / genetics
Mutation
Myeloproliferative Disorders* / genetics
Primary Myelofibrosis* / genetics
Thrombocythemia, Essential* / genetics

Substances

Calreticulin
Janus Kinase 2

Grants and funding